Dawei (Anhui) Pharmaceutical Co., Ltd.

To study the pharmacokinetic characteristics of a single oral dose of the test preparation (ibuprofen suspension, specification 100mL:2g, licensed by Dawei (Anhui) Pharmaceutical Co., Ltd.) and the reference preparation (ibuprofen suspension, specification 100mL:2g, trade name: Meilin, licensed by Shanghai Johnson Pharmaceutical Co., Ltd.) in healthy subjects under fasting and postprandial conditions, to compare the bioequivalence of the test preparation and the reference preparation, and to study the safety of the drug in healthy subjects

Main purpose: To study the single oral administration of the test preparation Juprezinc Granules (specification: 75mg, produced by Huayi Pharmaceutical Technology (Anhui) Co., Ltd. (certified by Dawei (Anhui) Pharmaceutical Co., Ltd.) in the fasting/postprandial state) ) and the reference preparation Polyprezinc granules (trade name: Promac®, specification: 75 mg; produced by ゼリア Shinshu Industry Co., Ltd.), the in vivo time course of Polyprezinc, verify the blood drug concentration analysis method and blood collection time, The rationality of the design of sampling volume, time interval, etc., preliminary evaluation of the bioequivalence of the two preparations and calculation of the intra-individual coefficient of variation provide a basis for the safe and reasonable use of the tested preparations. . Secondary purpose: To evaluate the safety of the test preparation and reference preparation (trade name: Promac®) of Polyprezinc Granules in healthy subjects.